These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 33858481)

  • 1. Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot study.
    Tokutsu A; Okada Y; Torimoto K; Tanaka Y
    Diabetol Metab Syndr; 2021 Apr; 13(1):45. PubMed ID: 33858481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
    Uemura F; Okada Y; Torimoto K; Tanaka Y
    Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Estimated Glycosylated Hemoglobin Using Flash Glucose Monitoring and Actual Measured Glycosylated Hemoglobin in a Chinese Population.
    Hu Y; Shen Y; Yan R; Li F; Ding B; Wang H; Su X; Ma J
    Diabetes Ther; 2020 Sep; 11(9):2019-2027. PubMed ID: 32696267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness of Oral Hypoglycemic Agents for Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes Mellitus: Using Flash Glucose Monitoring.
    Venkatachalapathy P; Mohandoss KKDA; Munisamy M; Sellappan M
    Curr Diabetes Rev; 2024 Jan; ():. PubMed ID: 38310479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Insulin Degludec and Insulin Glargine U300 on Day-to-Day Fasting Plasma Glucose Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study (Kobe Best Basal Insulin Study 2).
    Miura H; Sakaguchi K; Okada Y; Otowa-Suematsu N; Yamada T; So A; Komada H; Hirota Y; Kishi M; Takeda A; Tominaga Y; Nakamura T; Kuroki Y; Matsuda T; Iida K; Kajikawa M; Ohara T; Yokota K; Hara K; Tateya S; Tamori Y; Ogawa W
    Diabetes Ther; 2018 Dec; 9(6):2399-2406. PubMed ID: 30341665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c.
    Xu F; Zhao LH; Su JB; Chen T; Wang XQ; Chen JF; Wu G; Jin Y; Wang XH
    Diabetol Metab Syndr; 2014; 6(1):139. PubMed ID: 25530811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the effectiveness of using flash glucose monitoring on glycemic control for type 1 diabetes in Saudi Arabia.
    Alhodaib HI; Alsulihem S
    World J Diabetes; 2021 Nov; 12(11):1908-1916. PubMed ID: 34888015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
    Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin A1c modifies the association between triglyceride and time in hypoglycemia determined by flash glucose monitoring in adults with type 1 diabetes: implications for individualized therapy and decision-making.
    Liu Y; Yu J; Ma C; He S; Ping F; Zhang H; Li W; Xu L; Xiao X; Li Y
    Ann Transl Med; 2021 Apr; 9(7):537. PubMed ID: 33987235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring.
    Kawaguchi Y; Sawa J; Kumeda Y
    Diabetes Ther; 2020 Dec; 11(12):2945-2958. PubMed ID: 33063270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of sleep quality with glycemic variability assessed by flash glucose monitoring in patients with type 2 diabetes.
    Yang Y; Zhao LH; Li DD; Xu F; Wang XH; Lu CF; Wang CH; Yu C; Zhang XL; Ning LY; Wang XQ; Su JB; Wang LH
    Diabetol Metab Syndr; 2021 Sep; 13(1):102. PubMed ID: 34556157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous glucose monitoring shows a close correlation between mean glucose and time spent in hyperglycemia and hemoglobin A1c.
    Nielsen JK; Gravholt CH; Djurhuus CB; Brandt D; Becker J; Heinemann L; Christiansen JS
    J Diabetes Sci Technol; 2007 Nov; 1(6):857-63. PubMed ID: 19885157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of free style Libre-Flash Glucose Monitoring: Glycemic control of Type-1 Diabetes.
    Mohamed IAA; Talaat IM; Alghamdi HA; Allam G
    Pak J Med Sci; 2021; 37(7):1883-1889. PubMed ID: 34912412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes.
    Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N
    Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus.
    Gómez AM; Muñoz OM; Marin A; Fonseca MC; Rondon M; Robledo Gómez MA; Sanko A; Lujan D; García-Jaramillo M; León Vargas FM
    J Diabetes Sci Technol; 2018 Sep; 12(5):1007-1015. PubMed ID: 29451006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.
    Haak T; Hanaire H; Ajjan R; Hermanns N; Riveline JP; Rayman G
    Diabetes Ther; 2017 Feb; 8(1):55-73. PubMed ID: 28000140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.